Nabriva Therapeutics plc
Nabriva Therapeutics plc (NBRVF) stock FAQs
Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.
What is Nabriva Therapeutics plc (NBRVF) stock price today?
As of Dec 16, 2025, 9:00 PM UTC, Nabriva Therapeutics plc (NBRVF) stock is trading at $0.0001. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date NBRVF stock quotes for informed trading decisions.
What is Nabriva Therapeutics plc's market capitalization?
Nabriva Therapeutics plc (NBRVF) has a market capitalization of approximately $323.0. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Nabriva Therapeutics plc's size relative to other companies in the USD market. The market cap figure updates automatically as the NBRVF stock price changes.
What is the 52-week range for Nabriva Therapeutics plc stock?
Nabriva Therapeutics plc (NBRVF) stock has traded in a 52-week range of $0.00 — $0.0002. The 52-week range shows the highest and lowest prices at which NBRVF traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Nabriva Therapeutics plc stock price to this range provides context for recent price action.
How much trading volume does Nabriva Therapeutics plc stock have?
Nabriva Therapeutics plc (NBRVF) stock recently traded approximately 780 shares. Trading volume indicates market liquidity and investor interest in NBRVF. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Nabriva Therapeutics plc stock.
Does Nabriva Therapeutics plc pay dividends to shareholders?
Yes, Nabriva Therapeutics plc (NBRVF) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Nabriva Therapeutics plc stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.
What is Nabriva Therapeutics plc's intraday price range?
Today, Nabriva Therapeutics plc (NBRVF) stock has traded in a range of $0.0001 — $0.0001. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring NBRVF's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.
Where does AlphaPilot get Nabriva Therapeutics plc stock data?
AlphaPilot sources real-time NBRVF stock quotes, fundamental financial data, and historical price charts for Nabriva Therapeutics plc from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Nabriva Therapeutics plc stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of NBRVF stock performance.